Clinical Trials · NCT03928379
A Study of LY3305677 in Participants With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 24
- Start date
- Oct 2019
- Locations
- 1 site, Germany
- Primary endpoint
- Number of Participants with One or More Serious Adverse Event(s) (SAEs) Considered by the Investigator to be Related to Study Drug